Financial statements Pharmed
Balance sheet data of PHARMED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 8 366 904,78 | 8 377 278,50 | 9 825 324,60 | 10 783 638,93 | 12 597 531,70 | 11 510 808,90 |
| A. Fixed assets | 2 046 783,41 | 2 250 344,31 | 2 186 289,39 | 2 845 543,18 | 3 980 523,33 | 4 369 716,22 |
| B. Current assets | 6 320 121,37 | 6 126 934,19 | 7 639 035,21 | 7 938 095,75 | 8 617 003,37 | 7 141 092,68 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 8 366 904,78 | 8 377 278,50 | 9 825 324,60 | 10 783 638,93 | 12 597 531,70 | 11 510 808,90 |
| A. Equity | 5 898 164,16 | 6 418 729,19 | 7 591 262,53 | 8 508 831,51 | 9 876 825,17 | 10 319 011,16 |
| B. Liabilities and provisions for liabilities | 2 468 740,62 | 1 958 549,31 | 2 234 062,07 | 2 274 807,42 | 2 716 789,53 | 1 191 797,74 |
| I. Long-term liabilities | 292 184,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 176 556,62 | 1 958 549,31 | 2 234 062,07 | 2 274 807,42 | 2 716 789,53 | 1 191 797,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.